Clinical trials: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer
7 questions · 5 sources
ASCENT trial
How was the TRODELVY ASCENT trial in previously treated metastatic TNBC designed?
TRODELVY vs chemotherapy in metastatic TNBC (ASCENT): what was median progression-free survival?
On the page, select: Full Population PFS
On the page, select: Full Population PFS